DUBAI, United Arab Emirates — Gulf Scientific Corporation (GSC) recently participated at the Precision Medicine and Functional Genomics 2023 Conference in Doha, Qatar. As one of the main titanium sponsors of the event, GSC showcased its commitment to advancing healthcare through cutting-edge technologies and solutions. The event took place atContinue Reading
BioAro will infuse resources to set up genome labs, clinics to launch precision medicine, personalised treatment to upgrade healthcare service, train medical professionals that will extend people’s health-span and longevity and make the UAE a global leader in precision medicare Press Release Date: Dubai, UAE; Saturday, October 28, 2023 NewsContinue Reading
WARREN, N.J. — Tevogen Bio today announced positive topline results from its Proof-of-Concept (POC) clinical trial designed to evaluate the safety and feasibility of TVGN 489, the company’s first clinical product of its precision T Cell therapy platform, for the treatment of acute high-risk COVID-19 patients. TVGN 489 is a genetically unmodified, off-the-shelf, allogeneicContinue Reading
